User login
For MD-IQ use only
'Real food' called key to healthful eating; Peer mentors seek to prevent suicides
Nutritious eating need not involve counting calories, carbohydrates, or points, according to food and nutrition editor Paul Kita.
After talking with experts and studying various diets, Mr. Kita said he found an approach that works for him.
The key is eating “real food,” such as chicken, tomatoes, eggs, and avocados; avoiding processed foods; and not demonizing anything. Approaching food this way for 10 years has allowed Mr. Kita to keep his weight at 155 pounds – give or take 5, – he wrote in Men’s Health.
“I eat cookies. I eat carbs. I even drink coffee supposedly loaded with mycotoxins,” Mr. Kita wrote. “I [eat] fruits and vegetables with every meal and cut back on booze and desserts. I have two clementines or a banana or a split broiled tomato for breakfast. I eat a big salad of mixed greens or a side of coleslaw or a ripe, juicy pear for lunch.”
He said dinner might include sautéed spinach or a carrot salad and roasted sweet potatoes. “And then I either choose to have a beer with or after dinner or a simple dessert. If I’m not craving something sweet, I’ll have a cup of tea.”
He said he tries for about 30 grams of protein at each meal.
“Here’s my main takeaway ... if the plan you have for what you feed yourself causes you more stress and adds more work to your already-busy life, you’re not eating well. The best diet ... doesn’t have celebrity endorsements. The best diet is one that is based on the inclusion of healthful foods – not the exclusion of food groups.”
Students seek to prevent suicides
The beauty of mountains can be breathtaking for someone passing through. For residents, living in the shadow of the giants, however, can be isolating, especially for small mountain communities. Grand Junction, Colo., is located in a valley ringed by tall mountains, desert mesas, and red-rock cliffs. For local residents, and especially teenagers, it can feel like the end of the world.
“I know we can’t really fix this because it’s nature,” 17-year-old Victoria Mendoza said in an NPR interview. “I feel like the people in our valley feel like there’s only life inside of Grand Junction.”
Ms. Mendoza has fought depression, as have other members of her family and others in the community. Seven student suicides occurred in the 2016-2017 school year. “It felt like there was this cloud around our whole valley,” Ms. Mendoza said. “It got to a point where we were just waiting for the next one.”
Rural settings can foster the loneliness that, for some, is only cured by self-inflicted death. Of the top 10 U.S. states with the highest rates of suicide, 8 are located in the rural mountain West. The view of mental illness as a sign of personal weakness remains prevalent, and having ready access to guns is not helpful.
In Grand Junction, students have seized the reins of a suicide prevention in which they act as peer mentors to younger students that either seek help or appear to be floundering. The approach, called the Sources of Strength suicide program, exemplifies a broader shift in public health thinking that is taking place. In Grand Junction, the strategy is to zero in on the mental health and well-being of everyone. That encourages a sense of community, even in a setting of physical isolation.
Cannabidiol and substance-free living
With cannabis use becoming more part of the norm and with its legalization, the idea of altering the way we see the world is, for some, moving from a no-go option to a practice that can help ease the strains of life. For those who struggle with PTSD or other anxieties, cannabis can be a way to alleviate paranoia, anxiety, and mood swings without the use of prescription drugs.
Of course, there will be many who will overenthusiastically embrace the chance to legally alter themselves, such as what occurs with alcohol. Sobriety means different things to different people. Some alcoholics happily live with an occasional drink. They consider themselves on a path of sobriety. Others must go cold turkey forever. This is a different sobriety. Each can be effective and can bring happiness.
“Does using cannabidiol count as a strike against recovery or a substance-free lifestyle? This can lead into particularly tricky terrain as many people turn to cannabis products as a solution for all manner of ailments – from mental health to addiction. As we reckon with cannabis legalization as a country, perhaps what we really should be asking ourselves is how we’re going to redefine the traditional meaning of sobriety,” Amanda Scriver wrote in the Walrus.
“As cannabidiol gains popularity, we must give people the capacity to examine, evaluate, and possibly amend their own health, wellness, or recovery journey in a way that feels right for them. Yes, we need better medical understanding of cannabis and its related products, and yes, we also need training in the harm-reduction model. But we also need compassion and the courage to rethink old definitions,” Ms. Scriver wrote.
Masculinity tied to mental health
As a celebrity, Lenard Larry McKelvey, aka Charlamagne Tha God, makes his living being brash and bold. On his radio show, The Breakfast Club, he asks questions some do not want asked. But, like many, he is also anxious about the world. As a father, he worries about his daughters. As a black man, he worries about police brutality.
But unlike many, he has a forum and an audience. And he is using his forum to speak out about his fears and anxieties in the hope that it helps others deal with their demons. A recent example is his book, “Shook One: Anxiety Playing Tricks On Me” (Touchstone, 2018).
He is a strong advocate of therapy. “I go to therapy just to push those negative thoughts out of my mind. None of us can escape thinking negatively. Negative thoughts are going to pop up in your head. You’re going to have self-doubt sometimes; you’re going to be insecure sometimes. You’re going to worry about your kids; you’re going to worry about your wife, but it’s about pushing that %@C# out and not holding onto it. When you hold onto it, that’s when it grows,” he explained in an interview with the Boston Globe.
He espoused the freedom that comes from self-acceptance. “My whole life, people have said to me, ‘You can’t be soft.’ I don’t care about that anymore. I don’t care about how people perceive me when it comes to masculinity. You know what’s masculine? Masculine is taking care of your mind, your body, and your soul. We spend so much time on our body. We want that six-pack. But what about your mental health? What about your mental well-being? I go to the gym three, four times a week. Why can’t I put that same effort and same energy into getting mentally strong?”
Can extremists’ mindsets change?
The recent massacre at the Pittsburgh synagogue was yet another vile example of hatred and bigotry. But, in the United States and elsewhere, the shooter was one of many. Why?
According to an NPR piece, there are several possible explanations. Those brimming with racist hated might have little opportunity to get off that track. “We haven’t wanted to acknowledge that we have a problem with violent right-wing extremism in this kind of domestic terrorism,” said sociologist Pete Simi, PhD, of Chapman University in Orange, Calif. Dr. Simi has studied violent white nationalists and other hate groups for decades.
“White supremacy is really a problem throughout the United States,” Dr. Simi said. “It doesn’t know any geographic boundaries. It’s not isolated to either urban or rural or suburban – it cuts across all.”
There is little knowledge of how to deal with home-grown hatred. Banning immigrants perceived as being a threat is one attempt to deal with foreign-born terrorism, but that doesn’t work for citizens. For them, rehabilitation is possible, according to Dr. Simi, but it comes with a big price tag of revamped social, education, housing, and employment programs. Governments are loathe to take on those costs, in part because it is an admission that society is broken.
“A big, big problem that we face as a society is abdicating our responsibility in terms of providing this kind of social support and social safety net for individuals that suffer from mental health, as well as drug problems,” Dr. Simi said in the interview.
Small-scale local efforts, such as the Chicago-based Life After Hate, are working for change. How to scale up such efforts is a vexing problem.
Nutritious eating need not involve counting calories, carbohydrates, or points, according to food and nutrition editor Paul Kita.
After talking with experts and studying various diets, Mr. Kita said he found an approach that works for him.
The key is eating “real food,” such as chicken, tomatoes, eggs, and avocados; avoiding processed foods; and not demonizing anything. Approaching food this way for 10 years has allowed Mr. Kita to keep his weight at 155 pounds – give or take 5, – he wrote in Men’s Health.
“I eat cookies. I eat carbs. I even drink coffee supposedly loaded with mycotoxins,” Mr. Kita wrote. “I [eat] fruits and vegetables with every meal and cut back on booze and desserts. I have two clementines or a banana or a split broiled tomato for breakfast. I eat a big salad of mixed greens or a side of coleslaw or a ripe, juicy pear for lunch.”
He said dinner might include sautéed spinach or a carrot salad and roasted sweet potatoes. “And then I either choose to have a beer with or after dinner or a simple dessert. If I’m not craving something sweet, I’ll have a cup of tea.”
He said he tries for about 30 grams of protein at each meal.
“Here’s my main takeaway ... if the plan you have for what you feed yourself causes you more stress and adds more work to your already-busy life, you’re not eating well. The best diet ... doesn’t have celebrity endorsements. The best diet is one that is based on the inclusion of healthful foods – not the exclusion of food groups.”
Students seek to prevent suicides
The beauty of mountains can be breathtaking for someone passing through. For residents, living in the shadow of the giants, however, can be isolating, especially for small mountain communities. Grand Junction, Colo., is located in a valley ringed by tall mountains, desert mesas, and red-rock cliffs. For local residents, and especially teenagers, it can feel like the end of the world.
“I know we can’t really fix this because it’s nature,” 17-year-old Victoria Mendoza said in an NPR interview. “I feel like the people in our valley feel like there’s only life inside of Grand Junction.”
Ms. Mendoza has fought depression, as have other members of her family and others in the community. Seven student suicides occurred in the 2016-2017 school year. “It felt like there was this cloud around our whole valley,” Ms. Mendoza said. “It got to a point where we were just waiting for the next one.”
Rural settings can foster the loneliness that, for some, is only cured by self-inflicted death. Of the top 10 U.S. states with the highest rates of suicide, 8 are located in the rural mountain West. The view of mental illness as a sign of personal weakness remains prevalent, and having ready access to guns is not helpful.
In Grand Junction, students have seized the reins of a suicide prevention in which they act as peer mentors to younger students that either seek help or appear to be floundering. The approach, called the Sources of Strength suicide program, exemplifies a broader shift in public health thinking that is taking place. In Grand Junction, the strategy is to zero in on the mental health and well-being of everyone. That encourages a sense of community, even in a setting of physical isolation.
Cannabidiol and substance-free living
With cannabis use becoming more part of the norm and with its legalization, the idea of altering the way we see the world is, for some, moving from a no-go option to a practice that can help ease the strains of life. For those who struggle with PTSD or other anxieties, cannabis can be a way to alleviate paranoia, anxiety, and mood swings without the use of prescription drugs.
Of course, there will be many who will overenthusiastically embrace the chance to legally alter themselves, such as what occurs with alcohol. Sobriety means different things to different people. Some alcoholics happily live with an occasional drink. They consider themselves on a path of sobriety. Others must go cold turkey forever. This is a different sobriety. Each can be effective and can bring happiness.
“Does using cannabidiol count as a strike against recovery or a substance-free lifestyle? This can lead into particularly tricky terrain as many people turn to cannabis products as a solution for all manner of ailments – from mental health to addiction. As we reckon with cannabis legalization as a country, perhaps what we really should be asking ourselves is how we’re going to redefine the traditional meaning of sobriety,” Amanda Scriver wrote in the Walrus.
“As cannabidiol gains popularity, we must give people the capacity to examine, evaluate, and possibly amend their own health, wellness, or recovery journey in a way that feels right for them. Yes, we need better medical understanding of cannabis and its related products, and yes, we also need training in the harm-reduction model. But we also need compassion and the courage to rethink old definitions,” Ms. Scriver wrote.
Masculinity tied to mental health
As a celebrity, Lenard Larry McKelvey, aka Charlamagne Tha God, makes his living being brash and bold. On his radio show, The Breakfast Club, he asks questions some do not want asked. But, like many, he is also anxious about the world. As a father, he worries about his daughters. As a black man, he worries about police brutality.
But unlike many, he has a forum and an audience. And he is using his forum to speak out about his fears and anxieties in the hope that it helps others deal with their demons. A recent example is his book, “Shook One: Anxiety Playing Tricks On Me” (Touchstone, 2018).
He is a strong advocate of therapy. “I go to therapy just to push those negative thoughts out of my mind. None of us can escape thinking negatively. Negative thoughts are going to pop up in your head. You’re going to have self-doubt sometimes; you’re going to be insecure sometimes. You’re going to worry about your kids; you’re going to worry about your wife, but it’s about pushing that %@C# out and not holding onto it. When you hold onto it, that’s when it grows,” he explained in an interview with the Boston Globe.
He espoused the freedom that comes from self-acceptance. “My whole life, people have said to me, ‘You can’t be soft.’ I don’t care about that anymore. I don’t care about how people perceive me when it comes to masculinity. You know what’s masculine? Masculine is taking care of your mind, your body, and your soul. We spend so much time on our body. We want that six-pack. But what about your mental health? What about your mental well-being? I go to the gym three, four times a week. Why can’t I put that same effort and same energy into getting mentally strong?”
Can extremists’ mindsets change?
The recent massacre at the Pittsburgh synagogue was yet another vile example of hatred and bigotry. But, in the United States and elsewhere, the shooter was one of many. Why?
According to an NPR piece, there are several possible explanations. Those brimming with racist hated might have little opportunity to get off that track. “We haven’t wanted to acknowledge that we have a problem with violent right-wing extremism in this kind of domestic terrorism,” said sociologist Pete Simi, PhD, of Chapman University in Orange, Calif. Dr. Simi has studied violent white nationalists and other hate groups for decades.
“White supremacy is really a problem throughout the United States,” Dr. Simi said. “It doesn’t know any geographic boundaries. It’s not isolated to either urban or rural or suburban – it cuts across all.”
There is little knowledge of how to deal with home-grown hatred. Banning immigrants perceived as being a threat is one attempt to deal with foreign-born terrorism, but that doesn’t work for citizens. For them, rehabilitation is possible, according to Dr. Simi, but it comes with a big price tag of revamped social, education, housing, and employment programs. Governments are loathe to take on those costs, in part because it is an admission that society is broken.
“A big, big problem that we face as a society is abdicating our responsibility in terms of providing this kind of social support and social safety net for individuals that suffer from mental health, as well as drug problems,” Dr. Simi said in the interview.
Small-scale local efforts, such as the Chicago-based Life After Hate, are working for change. How to scale up such efforts is a vexing problem.
Nutritious eating need not involve counting calories, carbohydrates, or points, according to food and nutrition editor Paul Kita.
After talking with experts and studying various diets, Mr. Kita said he found an approach that works for him.
The key is eating “real food,” such as chicken, tomatoes, eggs, and avocados; avoiding processed foods; and not demonizing anything. Approaching food this way for 10 years has allowed Mr. Kita to keep his weight at 155 pounds – give or take 5, – he wrote in Men’s Health.
“I eat cookies. I eat carbs. I even drink coffee supposedly loaded with mycotoxins,” Mr. Kita wrote. “I [eat] fruits and vegetables with every meal and cut back on booze and desserts. I have two clementines or a banana or a split broiled tomato for breakfast. I eat a big salad of mixed greens or a side of coleslaw or a ripe, juicy pear for lunch.”
He said dinner might include sautéed spinach or a carrot salad and roasted sweet potatoes. “And then I either choose to have a beer with or after dinner or a simple dessert. If I’m not craving something sweet, I’ll have a cup of tea.”
He said he tries for about 30 grams of protein at each meal.
“Here’s my main takeaway ... if the plan you have for what you feed yourself causes you more stress and adds more work to your already-busy life, you’re not eating well. The best diet ... doesn’t have celebrity endorsements. The best diet is one that is based on the inclusion of healthful foods – not the exclusion of food groups.”
Students seek to prevent suicides
The beauty of mountains can be breathtaking for someone passing through. For residents, living in the shadow of the giants, however, can be isolating, especially for small mountain communities. Grand Junction, Colo., is located in a valley ringed by tall mountains, desert mesas, and red-rock cliffs. For local residents, and especially teenagers, it can feel like the end of the world.
“I know we can’t really fix this because it’s nature,” 17-year-old Victoria Mendoza said in an NPR interview. “I feel like the people in our valley feel like there’s only life inside of Grand Junction.”
Ms. Mendoza has fought depression, as have other members of her family and others in the community. Seven student suicides occurred in the 2016-2017 school year. “It felt like there was this cloud around our whole valley,” Ms. Mendoza said. “It got to a point where we were just waiting for the next one.”
Rural settings can foster the loneliness that, for some, is only cured by self-inflicted death. Of the top 10 U.S. states with the highest rates of suicide, 8 are located in the rural mountain West. The view of mental illness as a sign of personal weakness remains prevalent, and having ready access to guns is not helpful.
In Grand Junction, students have seized the reins of a suicide prevention in which they act as peer mentors to younger students that either seek help or appear to be floundering. The approach, called the Sources of Strength suicide program, exemplifies a broader shift in public health thinking that is taking place. In Grand Junction, the strategy is to zero in on the mental health and well-being of everyone. That encourages a sense of community, even in a setting of physical isolation.
Cannabidiol and substance-free living
With cannabis use becoming more part of the norm and with its legalization, the idea of altering the way we see the world is, for some, moving from a no-go option to a practice that can help ease the strains of life. For those who struggle with PTSD or other anxieties, cannabis can be a way to alleviate paranoia, anxiety, and mood swings without the use of prescription drugs.
Of course, there will be many who will overenthusiastically embrace the chance to legally alter themselves, such as what occurs with alcohol. Sobriety means different things to different people. Some alcoholics happily live with an occasional drink. They consider themselves on a path of sobriety. Others must go cold turkey forever. This is a different sobriety. Each can be effective and can bring happiness.
“Does using cannabidiol count as a strike against recovery or a substance-free lifestyle? This can lead into particularly tricky terrain as many people turn to cannabis products as a solution for all manner of ailments – from mental health to addiction. As we reckon with cannabis legalization as a country, perhaps what we really should be asking ourselves is how we’re going to redefine the traditional meaning of sobriety,” Amanda Scriver wrote in the Walrus.
“As cannabidiol gains popularity, we must give people the capacity to examine, evaluate, and possibly amend their own health, wellness, or recovery journey in a way that feels right for them. Yes, we need better medical understanding of cannabis and its related products, and yes, we also need training in the harm-reduction model. But we also need compassion and the courage to rethink old definitions,” Ms. Scriver wrote.
Masculinity tied to mental health
As a celebrity, Lenard Larry McKelvey, aka Charlamagne Tha God, makes his living being brash and bold. On his radio show, The Breakfast Club, he asks questions some do not want asked. But, like many, he is also anxious about the world. As a father, he worries about his daughters. As a black man, he worries about police brutality.
But unlike many, he has a forum and an audience. And he is using his forum to speak out about his fears and anxieties in the hope that it helps others deal with their demons. A recent example is his book, “Shook One: Anxiety Playing Tricks On Me” (Touchstone, 2018).
He is a strong advocate of therapy. “I go to therapy just to push those negative thoughts out of my mind. None of us can escape thinking negatively. Negative thoughts are going to pop up in your head. You’re going to have self-doubt sometimes; you’re going to be insecure sometimes. You’re going to worry about your kids; you’re going to worry about your wife, but it’s about pushing that %@C# out and not holding onto it. When you hold onto it, that’s when it grows,” he explained in an interview with the Boston Globe.
He espoused the freedom that comes from self-acceptance. “My whole life, people have said to me, ‘You can’t be soft.’ I don’t care about that anymore. I don’t care about how people perceive me when it comes to masculinity. You know what’s masculine? Masculine is taking care of your mind, your body, and your soul. We spend so much time on our body. We want that six-pack. But what about your mental health? What about your mental well-being? I go to the gym three, four times a week. Why can’t I put that same effort and same energy into getting mentally strong?”
Can extremists’ mindsets change?
The recent massacre at the Pittsburgh synagogue was yet another vile example of hatred and bigotry. But, in the United States and elsewhere, the shooter was one of many. Why?
According to an NPR piece, there are several possible explanations. Those brimming with racist hated might have little opportunity to get off that track. “We haven’t wanted to acknowledge that we have a problem with violent right-wing extremism in this kind of domestic terrorism,” said sociologist Pete Simi, PhD, of Chapman University in Orange, Calif. Dr. Simi has studied violent white nationalists and other hate groups for decades.
“White supremacy is really a problem throughout the United States,” Dr. Simi said. “It doesn’t know any geographic boundaries. It’s not isolated to either urban or rural or suburban – it cuts across all.”
There is little knowledge of how to deal with home-grown hatred. Banning immigrants perceived as being a threat is one attempt to deal with foreign-born terrorism, but that doesn’t work for citizens. For them, rehabilitation is possible, according to Dr. Simi, but it comes with a big price tag of revamped social, education, housing, and employment programs. Governments are loathe to take on those costs, in part because it is an admission that society is broken.
“A big, big problem that we face as a society is abdicating our responsibility in terms of providing this kind of social support and social safety net for individuals that suffer from mental health, as well as drug problems,” Dr. Simi said in the interview.
Small-scale local efforts, such as the Chicago-based Life After Hate, are working for change. How to scale up such efforts is a vexing problem.
Samuel Shem: Part II
Mr. Shem is the author of the satirical novel The House of God, which examined medical residency in the United States in the 1970s.
Mr. Shem is the author of the satirical novel The House of God, which examined medical residency in the United States in the 1970s.
Mr. Shem is the author of the satirical novel The House of God, which examined medical residency in the United States in the 1970s.
Biomarkers and concussions
A novel theory explains the variable efficacy of SSRIs, single-dose zoliflodacin is successful for uncomplicated urogenital gonorrhea, and drinking regular, caffeinated coffee is linked with a decreased risk of rosacea.
Amazon Alexa
Apple Podcasts
Spotify
A novel theory explains the variable efficacy of SSRIs, single-dose zoliflodacin is successful for uncomplicated urogenital gonorrhea, and drinking regular, caffeinated coffee is linked with a decreased risk of rosacea.
Amazon Alexa
Apple Podcasts
Spotify
A novel theory explains the variable efficacy of SSRIs, single-dose zoliflodacin is successful for uncomplicated urogenital gonorrhea, and drinking regular, caffeinated coffee is linked with a decreased risk of rosacea.
Amazon Alexa
Apple Podcasts
Spotify
Some statins worse than others for musculoskeletal adverse event onset time
The FDA Adverse Event Reporting System database Quarterly Data Files (Q1 2004 to Q3 2017) published by the FDA (downloaded in February 2018) was used to evaluate the adverse events associated with statin therapy. Among the seven statins looked at in this study, atorvastatin and rosuvastatin contributed to both the most cases of musculoskeletal adverse events and also to some of the shortest times to onset; atorvastatin was associated with 454 cases and a median time to onset of 24.5 days, and rosuvastatin was associated with 413 cases and a median time to onset of 30 days. Simvastatin also contributed to a large number of cases (409), but the median time to onset was significantly faster with the other two statins according to a Steel-Dwass test.
The study also looked at whether and how much concomitant use of nonstatin drugs affected time to onset, but it found that none of the drugs evaluated in the study had an effect on time to onset.
Read more about this study in Pharmacology Research & Perspectives.
The FDA Adverse Event Reporting System database Quarterly Data Files (Q1 2004 to Q3 2017) published by the FDA (downloaded in February 2018) was used to evaluate the adverse events associated with statin therapy. Among the seven statins looked at in this study, atorvastatin and rosuvastatin contributed to both the most cases of musculoskeletal adverse events and also to some of the shortest times to onset; atorvastatin was associated with 454 cases and a median time to onset of 24.5 days, and rosuvastatin was associated with 413 cases and a median time to onset of 30 days. Simvastatin also contributed to a large number of cases (409), but the median time to onset was significantly faster with the other two statins according to a Steel-Dwass test.
The study also looked at whether and how much concomitant use of nonstatin drugs affected time to onset, but it found that none of the drugs evaluated in the study had an effect on time to onset.
Read more about this study in Pharmacology Research & Perspectives.
The FDA Adverse Event Reporting System database Quarterly Data Files (Q1 2004 to Q3 2017) published by the FDA (downloaded in February 2018) was used to evaluate the adverse events associated with statin therapy. Among the seven statins looked at in this study, atorvastatin and rosuvastatin contributed to both the most cases of musculoskeletal adverse events and also to some of the shortest times to onset; atorvastatin was associated with 454 cases and a median time to onset of 24.5 days, and rosuvastatin was associated with 413 cases and a median time to onset of 30 days. Simvastatin also contributed to a large number of cases (409), but the median time to onset was significantly faster with the other two statins according to a Steel-Dwass test.
The study also looked at whether and how much concomitant use of nonstatin drugs affected time to onset, but it found that none of the drugs evaluated in the study had an effect on time to onset.
Read more about this study in Pharmacology Research & Perspectives.
FROM PHARMACOLOGY RESEARCH & PERSPECTIVES
Portable hematology analyzer gets FDA nod
The Food and Drug Administration has granted .
HemoScreen requires a single drop of blood and uses disposable cartridges that provide automatic sample preparation.
HemoScreen can analyze 20 standard complete blood count parameters and produces results within 5 minutes.
Study results suggested that HemoScreen provides results comparable to those of another hematology analyzer, Sysmex XE-2100 (J Clin Pathol. 2016 Aug;69[8]:720-5).
“The HemoScreen delivers lab accurate results,” Avishay Bransky, PhD, CEO of PixCell, said in a statement.
HemoScreen “would be especially useful” in physicians’ offices, emergency rooms, intensive care units, oncology clinics, and remote locations, he added.
HemoScreen makes use of a technology called viscoelastic focusing, which employs microfluidics and machine vision algorithms to analyze cells.
The Food and Drug Administration has granted .
HemoScreen requires a single drop of blood and uses disposable cartridges that provide automatic sample preparation.
HemoScreen can analyze 20 standard complete blood count parameters and produces results within 5 minutes.
Study results suggested that HemoScreen provides results comparable to those of another hematology analyzer, Sysmex XE-2100 (J Clin Pathol. 2016 Aug;69[8]:720-5).
“The HemoScreen delivers lab accurate results,” Avishay Bransky, PhD, CEO of PixCell, said in a statement.
HemoScreen “would be especially useful” in physicians’ offices, emergency rooms, intensive care units, oncology clinics, and remote locations, he added.
HemoScreen makes use of a technology called viscoelastic focusing, which employs microfluidics and machine vision algorithms to analyze cells.
The Food and Drug Administration has granted .
HemoScreen requires a single drop of blood and uses disposable cartridges that provide automatic sample preparation.
HemoScreen can analyze 20 standard complete blood count parameters and produces results within 5 minutes.
Study results suggested that HemoScreen provides results comparable to those of another hematology analyzer, Sysmex XE-2100 (J Clin Pathol. 2016 Aug;69[8]:720-5).
“The HemoScreen delivers lab accurate results,” Avishay Bransky, PhD, CEO of PixCell, said in a statement.
HemoScreen “would be especially useful” in physicians’ offices, emergency rooms, intensive care units, oncology clinics, and remote locations, he added.
HemoScreen makes use of a technology called viscoelastic focusing, which employs microfluidics and machine vision algorithms to analyze cells.
Bradycardia guidelines, hypertension’s risk in young adults, and more
This week on Cardiocast, guidelines for bradycardia set a new bar for shared decision-making in pacemaker placement, young adults with hypertension may be at higher CVD risk, how sleep quality affects cardiovascular risk, and a strong showing for exercise in patients with both heart failure and sleep apnea.
Tune in next Friday for the most exciting news from the scientific sessions of the American Heart Association, as told by the reporters who cover it.
Subscribe to Cardiocast wherever you get your podcasts.
This week on Cardiocast, guidelines for bradycardia set a new bar for shared decision-making in pacemaker placement, young adults with hypertension may be at higher CVD risk, how sleep quality affects cardiovascular risk, and a strong showing for exercise in patients with both heart failure and sleep apnea.
Tune in next Friday for the most exciting news from the scientific sessions of the American Heart Association, as told by the reporters who cover it.
Subscribe to Cardiocast wherever you get your podcasts.
This week on Cardiocast, guidelines for bradycardia set a new bar for shared decision-making in pacemaker placement, young adults with hypertension may be at higher CVD risk, how sleep quality affects cardiovascular risk, and a strong showing for exercise in patients with both heart failure and sleep apnea.
Tune in next Friday for the most exciting news from the scientific sessions of the American Heart Association, as told by the reporters who cover it.
Subscribe to Cardiocast wherever you get your podcasts.
Venous Venous Venous @VEITHsymposium
The Venous Venous Venous @VEITHsymposium program has become a popular staple of the meeting. With a mixture of didactic sessions and workshops, the Venous Venous Venous program, which will be held on Thursday, Friday, and Saturday, will cover the full gamut of venous disorders and their treatments, surgical, endovascular, and medical.
The didactic Program J (Sessions 63-67) on Superficial Venous Disease will be held on Thursday morning and early afternoon and will detail the latest developments in venous clinical examinations and imaging, superficial vein strategies and techniques, thermal and non-thermal ablation, and there will be a special session on venous societal issues and governance. Moderated by Elna M. Masuda, MD, and Marc A. Passman, MD, this special session will feature discussions of the Centers for Medicare & Medicaid policy update on venous ablation, dealing with MACRA, the RUC, and the reevaluation of phlebectomy, and more.
The didactic Program N (Sessions 88-92) on Deep Venous Disease will be all day Friday and will cover pelvic venous disorders, femoro-iliocaval interventions, deep vein reflux, wounds, and endovascular and open solutions for inferior vena cava disorders, and more.
The didactic Program R (Sessions 109-114) on Superficial Venous Disease will be held on Thursday morning and early afternoon and will cover all aspects of venous disease, from venous imaging, thrombophilia, schelrotherapy, phlebectomy, and more.
This year’s workshops will be held on Thursday afternoon and early evening, Nov. 15, and will feature video case presentations, and lectures and demonstrations on managing venous disease by leading experts in the field. In addition, there will be hands-on work station opportunities for participants to work with trained professionals to hone their skills.Two workshop modules are being offered this year:
1) Thrombus Management, which will focus on thromolysis, thrombectomry, the latest in stents and filters, difficult recanalizations, and issues in anticoagulation.
2) Superficial Venous Disease and Compression Management, which will deal with venous ablation, phelebctomy, schlerotherapy, and the critical areas of lymphedema, lipedema, and venous edema treatment, as well as wound care and compression.
The Venous Venous Venous @VEITHsymposium program has become a popular staple of the meeting. With a mixture of didactic sessions and workshops, the Venous Venous Venous program, which will be held on Thursday, Friday, and Saturday, will cover the full gamut of venous disorders and their treatments, surgical, endovascular, and medical.
The didactic Program J (Sessions 63-67) on Superficial Venous Disease will be held on Thursday morning and early afternoon and will detail the latest developments in venous clinical examinations and imaging, superficial vein strategies and techniques, thermal and non-thermal ablation, and there will be a special session on venous societal issues and governance. Moderated by Elna M. Masuda, MD, and Marc A. Passman, MD, this special session will feature discussions of the Centers for Medicare & Medicaid policy update on venous ablation, dealing with MACRA, the RUC, and the reevaluation of phlebectomy, and more.
The didactic Program N (Sessions 88-92) on Deep Venous Disease will be all day Friday and will cover pelvic venous disorders, femoro-iliocaval interventions, deep vein reflux, wounds, and endovascular and open solutions for inferior vena cava disorders, and more.
The didactic Program R (Sessions 109-114) on Superficial Venous Disease will be held on Thursday morning and early afternoon and will cover all aspects of venous disease, from venous imaging, thrombophilia, schelrotherapy, phlebectomy, and more.
This year’s workshops will be held on Thursday afternoon and early evening, Nov. 15, and will feature video case presentations, and lectures and demonstrations on managing venous disease by leading experts in the field. In addition, there will be hands-on work station opportunities for participants to work with trained professionals to hone their skills.Two workshop modules are being offered this year:
1) Thrombus Management, which will focus on thromolysis, thrombectomry, the latest in stents and filters, difficult recanalizations, and issues in anticoagulation.
2) Superficial Venous Disease and Compression Management, which will deal with venous ablation, phelebctomy, schlerotherapy, and the critical areas of lymphedema, lipedema, and venous edema treatment, as well as wound care and compression.
The Venous Venous Venous @VEITHsymposium program has become a popular staple of the meeting. With a mixture of didactic sessions and workshops, the Venous Venous Venous program, which will be held on Thursday, Friday, and Saturday, will cover the full gamut of venous disorders and their treatments, surgical, endovascular, and medical.
The didactic Program J (Sessions 63-67) on Superficial Venous Disease will be held on Thursday morning and early afternoon and will detail the latest developments in venous clinical examinations and imaging, superficial vein strategies and techniques, thermal and non-thermal ablation, and there will be a special session on venous societal issues and governance. Moderated by Elna M. Masuda, MD, and Marc A. Passman, MD, this special session will feature discussions of the Centers for Medicare & Medicaid policy update on venous ablation, dealing with MACRA, the RUC, and the reevaluation of phlebectomy, and more.
The didactic Program N (Sessions 88-92) on Deep Venous Disease will be all day Friday and will cover pelvic venous disorders, femoro-iliocaval interventions, deep vein reflux, wounds, and endovascular and open solutions for inferior vena cava disorders, and more.
The didactic Program R (Sessions 109-114) on Superficial Venous Disease will be held on Thursday morning and early afternoon and will cover all aspects of venous disease, from venous imaging, thrombophilia, schelrotherapy, phlebectomy, and more.
This year’s workshops will be held on Thursday afternoon and early evening, Nov. 15, and will feature video case presentations, and lectures and demonstrations on managing venous disease by leading experts in the field. In addition, there will be hands-on work station opportunities for participants to work with trained professionals to hone their skills.Two workshop modules are being offered this year:
1) Thrombus Management, which will focus on thromolysis, thrombectomry, the latest in stents and filters, difficult recanalizations, and issues in anticoagulation.
2) Superficial Venous Disease and Compression Management, which will deal with venous ablation, phelebctomy, schlerotherapy, and the critical areas of lymphedema, lipedema, and venous edema treatment, as well as wound care and compression.
VEITHsymposium: Focusing on (clinical) trials and tribulations
A hallmark of the VEITHsymposium has always been its focus on the results of recent and ongoing clinical trials, and this year is no exception. These trials will be presented by experts in their various fields who will discuss how the results will affect your daily practice.
A plethora of such clinical trials take center stage throughout the week and Tuesday alone has its fair share of highlighted studies.
For example, Tuesday morning, Jan D. Blankensteijn, MD, will discuss how and why the late results of the Dutch Randomised Endovascular Aneurysm Management (DREAM) and the Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (OVER) randomized controlled trials did not show the same late survival benefit for open repair as for EVAR and will address the issue of whether EVAR should be the treatment of choice for all anatomically suitable AAA patients.
Intracranial treatments for stroke will be a key interest of three trial presentations: Colin P. Derdeyn, MD, will present new findings from the Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) randomized controlled trial comparing intracranial stenting to best medical treatments, highlighting the high incidence of in-stent restenosis causing strokes that were observed. Alejandro M. Spiotta, MD, will discuss how the COMPASS Trial: a Direct Aspiration First Pass Technique (COMPASS) shows that new aspiration systems are equivalent to stentrievers for removing intracranial clots to treat acute strokes, and address when they appear to be actually better. In addition, L. Nelson Hopkins, MD, will present an update on the value of intracranial clot removal for acute strokes, highlighting the question of when a longer window after symptom onset (up to 24 hours) is acceptable, as seen in recent trials such as the Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo (DAWN) and Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke (EXTEND-IA TNK) studies.
Switching gears later in the day, the 1-year results of the Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE) multicenter randomized controlled trial, will be presented by Yann Gouëffic, MD, PhD.
Be sure to catch up with these trial results and others on Tuesday and the host of trials to be presented and discussed throughout the week at the 2018 VEITHsymposium.
A hallmark of the VEITHsymposium has always been its focus on the results of recent and ongoing clinical trials, and this year is no exception. These trials will be presented by experts in their various fields who will discuss how the results will affect your daily practice.
A plethora of such clinical trials take center stage throughout the week and Tuesday alone has its fair share of highlighted studies.
For example, Tuesday morning, Jan D. Blankensteijn, MD, will discuss how and why the late results of the Dutch Randomised Endovascular Aneurysm Management (DREAM) and the Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (OVER) randomized controlled trials did not show the same late survival benefit for open repair as for EVAR and will address the issue of whether EVAR should be the treatment of choice for all anatomically suitable AAA patients.
Intracranial treatments for stroke will be a key interest of three trial presentations: Colin P. Derdeyn, MD, will present new findings from the Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) randomized controlled trial comparing intracranial stenting to best medical treatments, highlighting the high incidence of in-stent restenosis causing strokes that were observed. Alejandro M. Spiotta, MD, will discuss how the COMPASS Trial: a Direct Aspiration First Pass Technique (COMPASS) shows that new aspiration systems are equivalent to stentrievers for removing intracranial clots to treat acute strokes, and address when they appear to be actually better. In addition, L. Nelson Hopkins, MD, will present an update on the value of intracranial clot removal for acute strokes, highlighting the question of when a longer window after symptom onset (up to 24 hours) is acceptable, as seen in recent trials such as the Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo (DAWN) and Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke (EXTEND-IA TNK) studies.
Switching gears later in the day, the 1-year results of the Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE) multicenter randomized controlled trial, will be presented by Yann Gouëffic, MD, PhD.
Be sure to catch up with these trial results and others on Tuesday and the host of trials to be presented and discussed throughout the week at the 2018 VEITHsymposium.
A hallmark of the VEITHsymposium has always been its focus on the results of recent and ongoing clinical trials, and this year is no exception. These trials will be presented by experts in their various fields who will discuss how the results will affect your daily practice.
A plethora of such clinical trials take center stage throughout the week and Tuesday alone has its fair share of highlighted studies.
For example, Tuesday morning, Jan D. Blankensteijn, MD, will discuss how and why the late results of the Dutch Randomised Endovascular Aneurysm Management (DREAM) and the Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (OVER) randomized controlled trials did not show the same late survival benefit for open repair as for EVAR and will address the issue of whether EVAR should be the treatment of choice for all anatomically suitable AAA patients.
Intracranial treatments for stroke will be a key interest of three trial presentations: Colin P. Derdeyn, MD, will present new findings from the Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) randomized controlled trial comparing intracranial stenting to best medical treatments, highlighting the high incidence of in-stent restenosis causing strokes that were observed. Alejandro M. Spiotta, MD, will discuss how the COMPASS Trial: a Direct Aspiration First Pass Technique (COMPASS) shows that new aspiration systems are equivalent to stentrievers for removing intracranial clots to treat acute strokes, and address when they appear to be actually better. In addition, L. Nelson Hopkins, MD, will present an update on the value of intracranial clot removal for acute strokes, highlighting the question of when a longer window after symptom onset (up to 24 hours) is acceptable, as seen in recent trials such as the Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo (DAWN) and Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke (EXTEND-IA TNK) studies.
Switching gears later in the day, the 1-year results of the Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE) multicenter randomized controlled trial, will be presented by Yann Gouëffic, MD, PhD.
Be sure to catch up with these trial results and others on Tuesday and the host of trials to be presented and discussed throughout the week at the 2018 VEITHsymposium.
Hypertension and CVD risk for young adults
The medical community is struggling to reach a vaccine for Hepatitis C virus, many teens don’t know that e-cigarettes contain nicotine, and there’s a duel in SLE classification criteria,
Amazon Alexa
Apple Podcasts
Spotify
The medical community is struggling to reach a vaccine for Hepatitis C virus, many teens don’t know that e-cigarettes contain nicotine, and there’s a duel in SLE classification criteria,
Amazon Alexa
Apple Podcasts
Spotify
The medical community is struggling to reach a vaccine for Hepatitis C virus, many teens don’t know that e-cigarettes contain nicotine, and there’s a duel in SLE classification criteria,
Amazon Alexa
Apple Podcasts
Spotify
Petrous Levounis: Substance Abuse Disorders


